Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

New diagnostic tests for pneumonia: what is their role in clinical practice?

File TM Jr.

Clin Chest Med. 2011 Sep;32(3):417-30. doi: 10.1016/j.ccm.2011.05.011. Epub 2011 Jul 12. Review.

PMID:
21867812
2.

The clinical impact of the detection of potential etiologic pathogens of community-acquired pneumonia.

Gelfer G, Leggett J, Myers J, Wang L, Gilbert DN.

Diagn Microbiol Infect Dis. 2015 Dec;83(4):400-6. doi: 10.1016/j.diagmicrobio.2015.08.001. Epub 2015 Aug 5.

PMID:
26341706
3.

The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.

Hoshina T, Nanishi E, Kanno S, Nishio H, Kusuhara K, Hara T.

J Infect Chemother. 2014 Oct;20(10):616-20. doi: 10.1016/j.jiac.2014.06.003. Epub 2014 Jul 11.

PMID:
25027057
4.

Procalcitonin is useful in identifying bacteraemia among children with pneumonia.

Nascimento-Carvalho CM, Cardoso MR, Barral A, Araújo-Neto CA, Guerin S, Saukkoriipi A, Paldanius M, Vainionpää R, Lebon P, Leinonen M, Ruuskanen O, Gendrel D.

Scand J Infect Dis. 2010 Sep;42(9):644-9. doi: 10.3109/00365541003796775.

PMID:
20438288
5.

Procalcitonin in children admitted to hospital with community acquired pneumonia.

Moulin F, Raymond J, Lorrot M, Marc E, Coste J, Iniguez JL, Kalifa G, Bohuon C, Gendrel D.

Arch Dis Child. 2001 Apr;84(4):332-6.

6.

Diagnostic tests for agents of community-acquired pneumonia.

Bartlett JG.

Clin Infect Dis. 2011 May;52 Suppl 4:S296-304. doi: 10.1093/cid/cir045. Review.

PMID:
21460288
7.

[Microbiological diagnosis of community-acquired pneumopathies].

Péan Y.

Med Mal Infect. 2011 Jan;41(1 Suppl 1):H2-4. doi: 10.1016/S0399-077X(11)70002-6. Review. French. No abstract available.

PMID:
21335251
8.

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ.

Clin Infect Dis. 2000 Aug;31(2):347-82. Epub 2000 Sep 7. No abstract available.

PMID:
10987697
9.

Clinical characterisation of pneumonia caused by atypical pathogens combining classic and novel predictors.

Masiá M, Gutiérrez F, Padilla S, Soldán B, Mirete C, Shum C, Hernández I, Royo G, Martin-Hidalgo A.

Clin Microbiol Infect. 2007 Feb;13(2):153-61.

10.

Inflammatory response in mixed viral-bacterial community-acquired pneumonia.

Bello S, Mincholé E, Fandos S, Lasierra AB, Ruiz MA, Simon AL, Panadero C, Lapresta C, Menendez R, Torres A.

BMC Pulm Med. 2014 Jul 29;14:123. doi: 10.1186/1471-2466-14-123.

11.

Point-of-care testing for community-acquired pneumonia.

Drancourt M, Gaydos CA, Summersgill JT, Raoult D.

Lancet Infect Dis. 2013 Aug;13(8):647-9. doi: 10.1016/S1473-3099(13)70165-8. No abstract available.

PMID:
23886323
12.

Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia.

Hohenthal U, Nuutila J, Lilius EM, Laitinen I, Nikoskelainen J, Kotilainen P.

BMC Infect Dis. 2006 Jan 24;6:11.

13.

The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children.

Korppi M, Don M, Valent F, Canciani M.

Acta Paediatr. 2008 Jul;97(7):943-7. doi: 10.1111/j.1651-2227.2008.00789.x. Epub 2008 Apr 15.

PMID:
18422803
14.

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.

Toikka P, Irjala K, Juvén T, Virkki R, Mertsola J, Leinonen M, Ruuskanen O.

Pediatr Infect Dis J. 2000 Jul;19(7):598-602.

PMID:
10917215
15.

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia.

Gilbert D, Gelfer G, Wang L, Myers J, Bajema K, Johnston M, Leggett J.

Diagn Microbiol Infect Dis. 2016 Sep;86(1):102-7. doi: 10.1016/j.diagmicrobio.2016.06.008. Epub 2016 Jun 15.

PMID:
27377675
16.

[Diagnostic work-up in community-acquired pneumonia].

Gillissen A, Reuner K.

MMW Fortschr Med. 2010 Nov 11;152(45):35-7. German. No abstract available.

PMID:
21319407
17.

What is the role of newer molecular tests in the management of CAP?

Gaydos CA.

Infect Dis Clin North Am. 2013 Mar;27(1):49-69. doi: 10.1016/j.idc.2012.11.012. Review.

PMID:
23398865
18.

Are radiological and biological investigations useful for antibiotic treatment of pediatric community acquired pneumonia?

Lepage P.

Pediatr Pulmonol Suppl. 1997;16:43-4. Review. No abstract available.

PMID:
9443191
19.

Microbiological investigations.

Salo P, Leinonen M.

Semin Respir Infect. 1999 Jun;14(2):128-34. Review.

PMID:
10391407
20.

[Investigations for etiologic causes in community-acquired pneumonia in children (besides imagery)].

Le Roux P.

Arch Pediatr. 1998;5 Suppl 1:28s-32s. Review. French.

PMID:
10223159

Supplemental Content

Support Center